Sigilon Therapeutics, Inc. - stock earnings
Stock symbol SGTX is outdated, potentially delisted? Maybe it is available on other exchange?
SGTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -6.7 million USD | 2.6 million USD |
| 2022Q3 | -8.7 million USD | 4.3 million USD |
| 2022Q2 | -14.3 million USD | 2.9 million USD |
| 2022Q1 | -13.9 million USD | 3.2 million USD |
| 2021Q4 | -17.7 million USD | 2.0 million USD |
| 2021Q3 | -20.2 million USD | 1.9 million USD |
| 2021Q2 | -20.4 million USD | 2.7 million USD |
| 2021Q1 | -19.0 million USD | 3.0 million USD |
| 2020Q4 | -15.2 million USD | 3.8 million USD |
SGTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -43.6 million USD | 12.9 million USD |
| 2021 | -77.3 million USD | 9.6 million USD |
| 2020 | -54.6 million USD | 13.4 million USD |
| 2019 | -43.9 million USD | 14.2 million USD |
| 2018 | -22.8 million USD | 4.6 million USD |
SGTX
Price: $22.47
52 week price:
Earnings Per Share: -12.86 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 104400
Market Capitalization: 18.2 million